Concepts (300)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Breast Feeding | 4 | 2023 | 113 | 1.520 |
Why?
|
| Prostatic Neoplasms | 17 | 2013 | 935 | 1.270 |
Why?
|
| Nigeria | 42 | 2012 | 86 | 0.940 |
Why?
|
| Prostate-Specific Antigen | 5 | 2007 | 118 | 0.620 |
Why?
|
| Early Detection of Cancer | 4 | 2013 | 336 | 0.510 |
Why?
|
| Middle Aged | 39 | 2023 | 10129 | 0.460 |
Why?
|
| Fatty Acids | 3 | 2010 | 127 | 0.440 |
Why?
|
| Rural Population | 2 | 2007 | 294 | 0.430 |
Why?
|
| Male | 58 | 2023 | 20025 | 0.430 |
Why?
|
| Adult | 44 | 2023 | 11712 | 0.430 |
Why?
|
| Patient Education as Topic | 2 | 2013 | 215 | 0.410 |
Why?
|
| Urban Population | 7 | 2007 | 333 | 0.380 |
Why?
|
| Humans | 66 | 2023 | 37093 | 0.360 |
Why?
|
| Infant, Newborn | 4 | 2023 | 894 | 0.360 |
Why?
|
| Aged | 24 | 2016 | 6741 | 0.360 |
Why?
|
| Infant | 5 | 2023 | 1046 | 0.360 |
Why?
|
| Blood Pressure | 17 | 2004 | 646 | 0.350 |
Why?
|
| Mothers | 2 | 2023 | 181 | 0.350 |
Why?
|
| Detergents | 1 | 2008 | 24 | 0.330 |
Why?
|
| Industry | 1 | 2008 | 22 | 0.320 |
Why?
|
| Anthropometry | 3 | 2007 | 97 | 0.310 |
Why?
|
| Occupational Exposure | 1 | 2008 | 79 | 0.310 |
Why?
|
| Lung Diseases | 1 | 2008 | 61 | 0.310 |
Why?
|
| Adolescent | 16 | 2023 | 5363 | 0.290 |
Why?
|
| Polymorphism, Genetic | 6 | 2012 | 191 | 0.290 |
Why?
|
| Female | 42 | 2023 | 20969 | 0.270 |
Why?
|
| Prostatectomy | 1 | 2006 | 63 | 0.260 |
Why?
|
| Incidence | 7 | 2012 | 922 | 0.260 |
Why?
|
| Aged, 80 and over | 8 | 2013 | 2379 | 0.250 |
Why?
|
| Odds Ratio | 4 | 2010 | 534 | 0.240 |
Why?
|
| Body Mass Index | 10 | 2007 | 854 | 0.240 |
Why?
|
| Case-Control Studies | 6 | 2012 | 1130 | 0.230 |
Why?
|
| Health Status Disparities | 1 | 2010 | 642 | 0.230 |
Why?
|
| Obesity | 7 | 2007 | 1067 | 0.230 |
Why?
|
| Apolipoproteins | 2 | 2002 | 22 | 0.220 |
Why?
|
| Diabetes Mellitus | 2 | 2013 | 485 | 0.210 |
Why?
|
| Hypertension | 10 | 2006 | 796 | 0.210 |
Why?
|
| Body Height | 3 | 2006 | 53 | 0.200 |
Why?
|
| Albuminuria | 2 | 2001 | 76 | 0.200 |
Why?
|
| Young Adult | 2 | 2023 | 4268 | 0.200 |
Why?
|
| Quality of Life | 1 | 2006 | 481 | 0.200 |
Why?
|
| Risk Assessment | 3 | 2010 | 753 | 0.200 |
Why?
|
| Diabetic Nephropathies | 1 | 2001 | 61 | 0.190 |
Why?
|
| Diabetes Complications | 1 | 2001 | 90 | 0.190 |
Why?
|
| Anemia, Sickle Cell | 5 | 1993 | 183 | 0.190 |
Why?
|
| Pilot Projects | 4 | 2010 | 661 | 0.180 |
Why?
|
| Lipids | 3 | 1999 | 235 | 0.180 |
Why?
|
| Child | 7 | 2023 | 3131 | 0.180 |
Why?
|
| Weight Gain | 1 | 2021 | 136 | 0.180 |
Why?
|
| Risk Factors | 16 | 2012 | 3562 | 0.170 |
Why?
|
| Body Weight | 6 | 1996 | 434 | 0.160 |
Why?
|
| United States | 13 | 2016 | 4223 | 0.160 |
Why?
|
| Developing Countries | 3 | 2001 | 99 | 0.160 |
Why?
|
| Steroid 17-alpha-Hydroxylase | 2 | 2012 | 10 | 0.160 |
Why?
|
| Overweight | 1 | 2021 | 247 | 0.160 |
Why?
|
| Pregnancy | 1 | 2023 | 1549 | 0.150 |
Why?
|
| Body Composition | 2 | 1995 | 162 | 0.150 |
Why?
|
| Diet | 3 | 2016 | 801 | 0.150 |
Why?
|
| Logistic Models | 3 | 2010 | 923 | 0.140 |
Why?
|
| Kidney Failure, Chronic | 2 | 2001 | 233 | 0.140 |
Why?
|
| Carotenoids | 1 | 2016 | 70 | 0.140 |
Why?
|
| Alleles | 4 | 2012 | 321 | 0.130 |
Why?
|
| Cross-Sectional Studies | 9 | 2016 | 2721 | 0.120 |
Why?
|
| Cytochrome P-450 CYP3A | 2 | 2012 | 24 | 0.120 |
Why?
|
| Genetic Variation | 6 | 2002 | 387 | 0.120 |
Why?
|
| Wilms Tumor | 1 | 2013 | 4 | 0.110 |
Why?
|
| Nutrition Disorders | 1 | 1993 | 12 | 0.110 |
Why?
|
| Mass Screening | 4 | 2006 | 462 | 0.110 |
Why?
|
| Nephrotic Syndrome | 1 | 1993 | 10 | 0.110 |
Why?
|
| Glomerulonephritis | 1 | 1993 | 13 | 0.110 |
Why?
|
| Health Services Accessibility | 3 | 2013 | 560 | 0.110 |
Why?
|
| Health Knowledge, Attitudes, Practice | 2 | 2013 | 864 | 0.110 |
Why?
|
| Educational Status | 4 | 2012 | 313 | 0.110 |
Why?
|
| Health Surveys | 4 | 2010 | 373 | 0.110 |
Why?
|
| Kidney Neoplasms | 1 | 2013 | 68 | 0.110 |
Why?
|
| Genetic Predisposition to Disease | 3 | 2012 | 628 | 0.110 |
Why?
|
| Nutritional Status | 1 | 1993 | 116 | 0.110 |
Why?
|
| Activities of Daily Living | 2 | 2004 | 105 | 0.100 |
Why?
|
| Socioeconomic Factors | 10 | 2012 | 1067 | 0.100 |
Why?
|
| Chromosomes, Human, Pair 8 | 1 | 2012 | 27 | 0.100 |
Why?
|
| Analysis of Variance | 5 | 2001 | 550 | 0.100 |
Why?
|
| Follow-Up Studies | 3 | 2013 | 974 | 0.100 |
Why?
|
| Nutrition Surveys | 1 | 1993 | 242 | 0.100 |
Why?
|
| Registries | 1 | 2013 | 335 | 0.100 |
Why?
|
| Metacarpus | 1 | 1991 | 4 | 0.100 |
Why?
|
| Patient Selection | 2 | 2010 | 164 | 0.100 |
Why?
|
| Time Factors | 2 | 2006 | 1742 | 0.100 |
Why?
|
| Regression Analysis | 4 | 2001 | 455 | 0.100 |
Why?
|
| Fingers | 1 | 1991 | 20 | 0.090 |
Why?
|
| Vital Capacity | 2 | 2008 | 39 | 0.090 |
Why?
|
| Treatment Outcome | 3 | 2013 | 1369 | 0.090 |
Why?
|
| Poverty | 1 | 2013 | 348 | 0.090 |
Why?
|
| Infant Food | 2 | 1980 | 14 | 0.090 |
Why?
|
| Cardiovascular Diseases | 5 | 2002 | 664 | 0.090 |
Why?
|
| Predictive Value of Tests | 2 | 2006 | 400 | 0.090 |
Why?
|
| Patient Acceptance of Health Care | 2 | 2012 | 404 | 0.090 |
Why?
|
| Dietary Fats | 1 | 2010 | 119 | 0.080 |
Why?
|
| Peak Expiratory Flow Rate | 1 | 2008 | 5 | 0.080 |
Why?
|
| Cholesterol, HDL | 2 | 1999 | 97 | 0.080 |
Why?
|
| Spirometry | 1 | 2008 | 33 | 0.080 |
Why?
|
| Priapism | 1 | 1988 | 2 | 0.080 |
Why?
|
| Respiratory Function Tests | 1 | 2008 | 55 | 0.080 |
Why?
|
| Forced Expiratory Volume | 1 | 2008 | 70 | 0.080 |
Why?
|
| Glycoproteins | 2 | 1999 | 106 | 0.080 |
Why?
|
| Lipoprotein(a) | 2 | 1998 | 5 | 0.080 |
Why?
|
| Leg Ulcer | 1 | 1987 | 8 | 0.080 |
Why?
|
| Prevalence | 3 | 2008 | 1455 | 0.080 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2012 | 767 | 0.070 |
Why?
|
| Urban Health | 4 | 2010 | 95 | 0.070 |
Why?
|
| Prostatic Hyperplasia | 2 | 2006 | 34 | 0.070 |
Why?
|
| Reference Values | 3 | 1999 | 212 | 0.070 |
Why?
|
| Physical Examination | 2 | 2005 | 43 | 0.070 |
Why?
|
| Child, Preschool | 4 | 2013 | 1418 | 0.070 |
Why?
|
| Family Planning Services | 1 | 1987 | 30 | 0.070 |
Why?
|
| Southeastern United States | 3 | 2016 | 49 | 0.070 |
Why?
|
| Motor Activity | 2 | 2007 | 418 | 0.070 |
Why?
|
| Sex Characteristics | 3 | 1999 | 230 | 0.070 |
Why?
|
| West Indies | 1 | 2006 | 13 | 0.070 |
Why?
|
| World Health Organization | 1 | 2006 | 31 | 0.070 |
Why?
|
| Family Characteristics | 1 | 1987 | 108 | 0.070 |
Why?
|
| Sickness Impact Profile | 1 | 2006 | 21 | 0.070 |
Why?
|
| Appetite | 1 | 2006 | 21 | 0.070 |
Why?
|
| Urinary Incontinence | 1 | 2006 | 15 | 0.070 |
Why?
|
| Erectile Dysfunction | 1 | 2006 | 38 | 0.070 |
Why?
|
| Fatigue | 1 | 2006 | 83 | 0.060 |
Why?
|
| Sex Factors | 7 | 1995 | 898 | 0.060 |
Why?
|
| Cardiovascular Physiological Phenomena | 1 | 2004 | 10 | 0.060 |
Why?
|
| Promoter Regions, Genetic | 2 | 2004 | 515 | 0.060 |
Why?
|
| Prostaglandin-Endoperoxide Synthases | 1 | 2004 | 41 | 0.060 |
Why?
|
| Research Design | 1 | 2006 | 313 | 0.060 |
Why?
|
| Lipoproteins | 2 | 2002 | 64 | 0.060 |
Why?
|
| Adenocarcinoma | 1 | 2006 | 251 | 0.060 |
Why?
|
| Severity of Illness Index | 1 | 2006 | 610 | 0.060 |
Why?
|
| Haplotypes | 1 | 2004 | 182 | 0.060 |
Why?
|
| Isoenzymes | 1 | 2004 | 161 | 0.060 |
Why?
|
| Smoking | 4 | 2011 | 940 | 0.060 |
Why?
|
| Cohort Studies | 4 | 2013 | 1492 | 0.050 |
Why?
|
| Pain | 1 | 2006 | 251 | 0.050 |
Why?
|
| Prospective Studies | 3 | 2016 | 1378 | 0.050 |
Why?
|
| Gene Frequency | 2 | 2002 | 195 | 0.050 |
Why?
|
| Caribbean Region | 2 | 2012 | 69 | 0.050 |
Why?
|
| Apolipoprotein A-I | 2 | 1999 | 21 | 0.050 |
Why?
|
| Mixed Function Oxygenases | 1 | 2002 | 34 | 0.050 |
Why?
|
| Lung Diseases, Obstructive | 1 | 2002 | 2 | 0.050 |
Why?
|
| Trinucleotide Repeats | 1 | 2001 | 4 | 0.050 |
Why?
|
| Cytochrome P-450 Enzyme System | 1 | 2002 | 92 | 0.050 |
Why?
|
| Circadian Rhythm | 1 | 2004 | 225 | 0.050 |
Why?
|
| Linkage Disequilibrium | 1 | 2001 | 85 | 0.050 |
Why?
|
| Social Class | 4 | 1996 | 247 | 0.050 |
Why?
|
| Genotype | 3 | 1999 | 730 | 0.050 |
Why?
|
| Diabetes Mellitus, Type 1 | 1 | 2001 | 68 | 0.050 |
Why?
|
| Chi-Square Distribution | 2 | 1999 | 225 | 0.050 |
Why?
|
| Electrocardiography | 2 | 1999 | 156 | 0.050 |
Why?
|
| Adipose Tissue | 2 | 1994 | 177 | 0.050 |
Why?
|
| Diabetic Retinopathy | 1 | 2001 | 68 | 0.050 |
Why?
|
| Physicians, Women | 1 | 2000 | 4 | 0.050 |
Why?
|
| Salaries and Fringe Benefits | 1 | 2000 | 12 | 0.050 |
Why?
|
| Receptors, Androgen | 1 | 2001 | 126 | 0.050 |
Why?
|
| Internal Medicine | 1 | 2000 | 24 | 0.050 |
Why?
|
| Feeding Behavior | 2 | 1996 | 454 | 0.050 |
Why?
|
| Sampling Studies | 3 | 1996 | 61 | 0.050 |
Why?
|
| Triglycerides | 2 | 1999 | 138 | 0.050 |
Why?
|
| Infant Nutritional Physiological Phenomena | 1 | 1980 | 36 | 0.040 |
Why?
|
| Complement Inactivator Proteins | 1 | 1999 | 1 | 0.040 |
Why?
|
| Hypertrophy, Left Ventricular | 1 | 1999 | 45 | 0.040 |
Why?
|
| Apolipoproteins C | 1 | 1999 | 3 | 0.040 |
Why?
|
| beta 2-Glycoprotein I | 1 | 1999 | 2 | 0.040 |
Why?
|
| Molecular Chaperones | 1 | 1999 | 61 | 0.040 |
Why?
|
| Cholesterol, LDL | 1 | 1999 | 68 | 0.040 |
Why?
|
| Apolipoproteins A | 1 | 1998 | 1 | 0.040 |
Why?
|
| Kringles | 1 | 1998 | 5 | 0.040 |
Why?
|
| Femur Head | 1 | 1998 | 3 | 0.040 |
Why?
|
| Pelvic Bones | 1 | 1998 | 4 | 0.040 |
Why?
|
| Fetal Hemoglobin | 2 | 1988 | 14 | 0.040 |
Why?
|
| Body Constitution | 2 | 1997 | 8 | 0.040 |
Why?
|
| Occupational Health | 1 | 1998 | 29 | 0.040 |
Why?
|
| Apolipoproteins E | 1 | 1999 | 129 | 0.040 |
Why?
|
| Neoplasm Staging | 2 | 2013 | 275 | 0.040 |
Why?
|
| Hip Fractures | 1 | 1998 | 23 | 0.040 |
Why?
|
| Hyperlipoproteinemias | 1 | 1997 | 2 | 0.040 |
Why?
|
| Occupations | 4 | 2001 | 23 | 0.040 |
Why?
|
| Diet, Atherogenic | 1 | 1996 | 6 | 0.040 |
Why?
|
| Exercise | 1 | 2001 | 613 | 0.030 |
Why?
|
| Coronary Disease | 1 | 1996 | 124 | 0.030 |
Why?
|
| Blood Pressure Determination | 1 | 1994 | 52 | 0.030 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 2001 | 643 | 0.030 |
Why?
|
| Radiotherapy, Adjuvant | 1 | 2013 | 16 | 0.030 |
Why?
|
| Neoadjuvant Therapy | 1 | 2013 | 13 | 0.030 |
Why?
|
| Adrenalectomy | 1 | 2013 | 25 | 0.030 |
Why?
|
| Chemotherapy, Adjuvant | 1 | 2013 | 37 | 0.030 |
Why?
|
| Kenya | 1 | 2013 | 50 | 0.030 |
Why?
|
| Sodium | 1 | 1993 | 103 | 0.030 |
Why?
|
| Potassium | 1 | 1993 | 112 | 0.030 |
Why?
|
| Disease-Free Survival | 1 | 2013 | 113 | 0.030 |
Why?
|
| Creatinine | 1 | 1993 | 103 | 0.030 |
Why?
|
| Combined Modality Therapy | 1 | 2013 | 148 | 0.030 |
Why?
|
| Nutritive Value | 1 | 1993 | 28 | 0.030 |
Why?
|
| Population Surveillance | 1 | 1994 | 238 | 0.030 |
Why?
|
| Biopsy | 1 | 1993 | 164 | 0.030 |
Why?
|
| Nutritional Requirements | 1 | 1993 | 36 | 0.030 |
Why?
|
| Age Factors | 2 | 1993 | 1033 | 0.030 |
Why?
|
| Longitudinal Studies | 2 | 1998 | 885 | 0.030 |
Why?
|
| SEER Program | 1 | 2012 | 91 | 0.030 |
Why?
|
| Occupational Diseases | 1 | 1992 | 47 | 0.030 |
Why?
|
| Survival Rate | 1 | 1993 | 311 | 0.030 |
Why?
|
| Survival Analysis | 1 | 2013 | 325 | 0.030 |
Why?
|
| Jamaica | 1 | 2012 | 11 | 0.030 |
Why?
|
| DNA Primers | 2 | 2004 | 286 | 0.030 |
Why?
|
| Cameroon | 1 | 2012 | 38 | 0.030 |
Why?
|
| Preventive Health Services | 1 | 2012 | 64 | 0.030 |
Why?
|
| Internet | 1 | 2013 | 211 | 0.020 |
Why?
|
| Genetic Association Studies | 1 | 2012 | 114 | 0.020 |
Why?
|
| Hemoglobins | 2 | 1990 | 107 | 0.020 |
Why?
|
| Heart Rate | 2 | 1995 | 253 | 0.020 |
Why?
|
| Genetic Markers | 3 | 2002 | 142 | 0.020 |
Why?
|
| Students | 2 | 1993 | 519 | 0.020 |
Why?
|
| Glutathione Transferase | 1 | 2011 | 88 | 0.020 |
Why?
|
| Radiography | 1 | 1991 | 72 | 0.020 |
Why?
|
| Base Sequence | 2 | 2004 | 997 | 0.020 |
Why?
|
| Hand | 1 | 1991 | 31 | 0.020 |
Why?
|
| Gene Deletion | 1 | 2011 | 166 | 0.020 |
Why?
|
| Prognosis | 1 | 1993 | 739 | 0.020 |
Why?
|
| Mutation, Missense | 2 | 2002 | 83 | 0.020 |
Why?
|
| Glucosephosphate Dehydrogenase Deficiency | 1 | 1990 | 1 | 0.020 |
Why?
|
| Tennessee | 1 | 2010 | 70 | 0.020 |
Why?
|
| Random Allocation | 2 | 1987 | 139 | 0.020 |
Why?
|
| Sickle Cell Trait | 1 | 1990 | 17 | 0.020 |
Why?
|
| Stress, Psychological | 1 | 1995 | 583 | 0.020 |
Why?
|
| Income | 1 | 2010 | 140 | 0.020 |
Why?
|
| Hematocrit | 1 | 1988 | 18 | 0.020 |
Why?
|
| Needs Assessment | 1 | 2010 | 170 | 0.020 |
Why?
|
| Community Health Services | 1 | 2010 | 185 | 0.020 |
Why?
|
| Somatotypes | 1 | 1987 | 4 | 0.020 |
Why?
|
| Homozygote | 1 | 1987 | 77 | 0.020 |
Why?
|
| Uric Acid | 1 | 1987 | 26 | 0.020 |
Why?
|
| Retrospective Studies | 1 | 2013 | 2026 | 0.020 |
Why?
|
| Selection Bias | 1 | 2006 | 11 | 0.020 |
Why?
|
| Students, Medical | 1 | 1988 | 130 | 0.020 |
Why?
|
| Hypercholesterolemia | 1 | 2006 | 38 | 0.020 |
Why?
|
| Age Distribution | 2 | 1997 | 225 | 0.020 |
Why?
|
| Sex Distribution | 2 | 1997 | 215 | 0.020 |
Why?
|
| Palpation | 1 | 2005 | 3 | 0.020 |
Why?
|
| Rectum | 1 | 2005 | 22 | 0.020 |
Why?
|
| Alcohol Drinking | 3 | 1997 | 519 | 0.020 |
Why?
|
| Posture | 1 | 2004 | 58 | 0.010 |
Why?
|
| Blood Pressure Monitoring, Ambulatory | 1 | 2004 | 63 | 0.010 |
Why?
|
| Life Style | 2 | 1996 | 308 | 0.010 |
Why?
|
| Cyclooxygenase 2 | 1 | 2004 | 104 | 0.010 |
Why?
|
| Adaptation, Physiological | 1 | 2004 | 109 | 0.010 |
Why?
|
| Apolipoproteins D | 1 | 2002 | 1 | 0.010 |
Why?
|
| Aging | 1 | 1987 | 664 | 0.010 |
Why?
|
| Forced Expiratory Flow Rates | 1 | 2002 | 2 | 0.010 |
Why?
|
| DNA, Neoplasm | 1 | 2002 | 92 | 0.010 |
Why?
|
| Minisatellite Repeats | 1 | 2001 | 18 | 0.010 |
Why?
|
| Africa | 1 | 2001 | 76 | 0.010 |
Why?
|
| North America | 1 | 2001 | 67 | 0.010 |
Why?
|
| Asia | 1 | 2001 | 75 | 0.010 |
Why?
|
| Recreation | 1 | 2001 | 32 | 0.010 |
Why?
|
| Private Practice | 1 | 2000 | 2 | 0.010 |
Why?
|
| Group Practice | 1 | 2000 | 8 | 0.010 |
Why?
|
| Pennsylvania | 1 | 2000 | 42 | 0.010 |
Why?
|
| Membrane Proteins | 1 | 2004 | 517 | 0.010 |
Why?
|
| Polymerase Chain Reaction | 1 | 2001 | 448 | 0.010 |
Why?
|
| Bottle Feeding | 1 | 1980 | 14 | 0.010 |
Why?
|
| Hypoglycemic Agents | 1 | 2001 | 160 | 0.010 |
Why?
|
| Diastole | 1 | 1999 | 42 | 0.010 |
Why?
|
| Insulin | 1 | 2001 | 236 | 0.010 |
Why?
|
| Systole | 1 | 1999 | 61 | 0.010 |
Why?
|
| Evaluation Studies as Topic | 1 | 1979 | 54 | 0.010 |
Why?
|
| Clusterin | 1 | 1999 | 9 | 0.010 |
Why?
|
| Family | 1 | 2000 | 173 | 0.010 |
Why?
|
| Electrophoresis, Agar Gel | 1 | 1998 | 28 | 0.010 |
Why?
|
| Femur Neck | 1 | 1998 | 4 | 0.010 |
Why?
|
| Femur | 1 | 1998 | 36 | 0.010 |
Why?
|
| Bone Density | 1 | 1998 | 75 | 0.010 |
Why?
|
| Risk | 1 | 1998 | 267 | 0.010 |
Why?
|
| Attitude to Health | 1 | 1980 | 325 | 0.010 |
Why?
|
| Western World | 1 | 1996 | 2 | 0.010 |
Why?
|
| Government Agencies | 1 | 1996 | 10 | 0.010 |
Why?
|
| Health Education | 1 | 1980 | 338 | 0.010 |
Why?
|
| Phenotype | 1 | 1999 | 689 | 0.010 |
Why?
|
| Differential Threshold | 1 | 1995 | 5 | 0.010 |
Why?
|
| Africa, Western | 1 | 1995 | 18 | 0.010 |
Why?
|
| Behavior | 1 | 1995 | 32 | 0.010 |
Why?
|
| Physical Exertion | 1 | 1995 | 26 | 0.010 |
Why?
|
| Stroke Volume | 1 | 1995 | 89 | 0.010 |
Why?
|
| Adaptation, Psychological | 1 | 1998 | 385 | 0.010 |
Why?
|
| Neuropsychological Tests | 1 | 1995 | 259 | 0.010 |
Why?
|
| Clinical Protocols | 1 | 1994 | 36 | 0.010 |
Why?
|
| Government | 1 | 1992 | 6 | 0.010 |
Why?
|
| Sensitivity and Specificity | 1 | 1994 | 562 | 0.010 |
Why?
|
| Biometry | 1 | 1992 | 11 | 0.010 |
Why?
|
| Skinfold Thickness | 1 | 1992 | 7 | 0.010 |
Why?
|
| Multivariate Analysis | 1 | 1993 | 583 | 0.010 |
Why?
|
| Reproducibility of Results | 1 | 1994 | 935 | 0.010 |
Why?
|
| Universities | 1 | 1993 | 442 | 0.010 |
Why?
|
| Proteinuria | 1 | 1990 | 50 | 0.010 |
Why?
|
| Antihypertensive Agents | 1 | 1992 | 284 | 0.010 |
Why?
|
| Cross-Cultural Comparison | 1 | 1988 | 107 | 0.000 |
Why?
|
| Cholesterol | 1 | 1988 | 205 | 0.000 |
Why?
|